IC50: oxidoreductase enzyme[1]
EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1].
EPI-589 exhibits a significant improvement in cerebrospinal fluid (CSF) and plasma-based biomarkers known to be associated with neuroinflammation and ALS disease progression[2].
[1]. BioElectron's EPI-589 Shows Positive Results in ALS Patients in Phase 2a Trial
[2]. Phase IIa trial of EPI-589 in ALS shows improvement in CSF
















